Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile
Kevin J. Fowler Principal The Voice of the Patient

@gratefull080504

Consulting business: recruiting early intervention kidney disease + kidney transplant trials;Moved from Chicago back home to STL; Move treatment of CKD upstream

ID: 102078380

linkhttp://linkedin.com/in/kevinjohnfowler calendar_today05-01-2010 14:44:23

25,25K Tweet

5,5K Followers

2,2K Following

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

The approval of the MediBeacon Inc.of the TGfR is a big first step in the advancement of #kidney health. eGFR is an insensitive biomarker that many times does not provide an accurate assessment of kidney function. This has implications in being placed on dialysis prematurely,

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

While this is exciting news, will this innovation reach the people that really need access to the treatment? Will this treatment reduce the fact that 33% of people on dialysis are African- American? #nephjc

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

I am grateful to contribute to this Patient Reported Outcome Measure with Devin Peipert amywaterman John Friedewald + Daniela Ladner MD While I am grateful for this project, it is important to recognize that it has been known for some time of the cognitive issues associated with

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

I applied for American Society of Transplantation (AST) membership + received this response: "While we find your transplant advocacy work impressive and honorable, you unfortunately do not qualify for AST membership at this time.ย  Our current membership bylaws require members to have a direct scientific or

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

I would like to thank Maarten Naesens, MD ESOTtransplant Transplant International for the opportunity to write my position statement on where the field of transplantation needs to shift to. Now is the time to improve quality and participation of life after transplant.

I would like to thank Maarten Naesens, MD <a href="/ESOTtransplant/">ESOTtransplant</a>  <a href="/Transpl_Int/">Transplant International</a>  for the opportunity to write my position statement on where the field of transplantation needs to shift to. Now is the time to improve quality and participation of life after transplant.
Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

I hope that my article and this special issue of Transplant International Life after Traansplantation serves as a platform to improve QOL + particpation in life for transplant recipients cc ESOTtransplant #openaccess #organdonation

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

Today NephCure is celebrating the first ever #FSGS awareness day. Due to the collaboration between the nephrology community + NephCure the future has never looked better for people with #FSGS. I encourage you to sign up through the link below. I will be there tonight.

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

Amidst the excitement surrounding CONFIDENCE data, how many nephrologists are actually prescribing finerenone or SGLT2 inhibitors? My sense is that utilization of both medications quite low individually. If I am mistaken, please correct me. Otherwise, I remain skeptical on

Kevin J. Fowler Principal The Voice of the Patient (@gratefull080504) 's Twitter Profile Photo

This is a very sobering story for people who have received a kidney transplant. For the over 20 years that I have had my kidney transplant, I have chosen to remain on brand. Why? I want to ensure the consistency of my supply and to avoid the consequences of switching from one